Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: Effect of PDE5 Inhibition on Adipose Metabolism in Humans [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the effects of PDE5 inhibition on adipose metabolism in adults with obesity; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PDE5 inhibitor (unspecified)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Obesity | Phase 2 | Status: COMPLETED